Gastric Stump Cancer After Distal Gastrectomy for Benign Disease: Clinicopathological Features and Surgical Outcomes |
| |
Authors: | Alberto Di Leo Corrado Pedrazzani Maria Bencivenga Arianna Coniglio Fausto Rosa Paolo Morgani Daniele Marrelli Alberto Marchet Luca Cozzaglio Simone Giacopuzzi Guido Alberto Massimo Tiberio Giovanni Battista Doglietto Giovanni Vittimberga Franco Roviello Francesco Ricci |
| |
Institution: | 1. Unit of General Surgery, Rovereto Hospital, APSS of Trento, Trento, Italy 2. Unit of Upper G.I. Surgery, University of Verona, Verona, Italy 3. Surgical Clinic, University of Brescia, Brescia, Italy 4. Department of Digestive Surgery, Catholic University of Rome, Rome, Italy 5. Department of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy 6. Division of Surgical Oncology, University of Siena, Siena, Italy 7. Department of Oncological and Surgical Science, University of Padua, Padua, Italy 8. Division of Surgical Oncology, Humanitas Hospital, Milan, Italy
|
| |
Abstract: | Purpose The purpose of the present study was to analyze clinicopathologic features and long-term prognosis of gastric stump cancer (GSC) arising in the remnant stomach 5 years or later after partial gastrectomy for benign disease. Methods We reviewed the results of 176 patients resected with curative intent for GSC at 8 Italian centers belonging to the Italian Research Group for Gastric Cancer (GIRCG). The median (range) follow-up time for surviving patients was 71.2 (6–207) months. Results One hundred forty-six patients were men, the mean age at the time of diagnosis was 69.2 years, and the great majority (167 cases) underwent Billroth II reconstruction. R0 resection was achieved in 158 (90 %) patients, and in 94 (53 %) lymph node dissection was ≥D2. Postoperative mortality and complication rates were 6.2 and 43.2 %, respectively. T1 tumor was diagnosed in 45 (25 %) cases. Lymph node metastases were evident in 86 patients (49 %). Thirteen patients had involvement of the jejunal mesentery nodes (pJN+); five cases were T2–T3 and eight cases were T4. Overall 5-year survival rate was 53.1 %. Five-year survival rates were 68.1, 37.8, and 33.1 % for pT1, pT2-3, and pT4 tumors, respectively (P = 0.001). Five-year survival rate was 56.5 % for node-negative tumors (pN0), 32.3 % for tumors with nodal metastases without involvement of jejunal mesentery nodes (pN+), and 17.1 % for tumors with involvement of jejunal mesentery nodes (pJN+) (P = 0.002). Conclusions Our study suggests that an aggressive surgical approach can achieve a satisfactory outcome in GSC. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|